Clinical Trial
doi: 10.1002/bod.2510090111.
Bioequivalence study of two liquid formulations of benzydamine
Affiliations
- PMID: 3342282
- DOI: 10.1002/bod.2510090111
Item in Clipboard
Clinical Trial
Bioequivalence study of two liquid formulations of benzydamine
Biopharm Drug Dispos.
1988 Jan-Feb.
Abstract
A bioequivalence study of two liquid formulations containing benzydamine hydrochloride was carried out to evaluate the influence of a change of the excipients and the addition of a flavouring agent, ICEBERG AR 84/05/15, on the absorption of benzydamine. No statistically significant differences were observed suggesting that the two formulations are bioequivalent.
Similar articles
-
Use of ultrasound to enhance percutaneous absorption of benzydamine.Phys Ther. 1989 Feb;69(2):113-8. doi: 10.1093/ptj/69.2.113. Phys Ther. 1989. PMID: 2913579 Clinical Trial.
-
Ocular absorption of benzydamine by the rabbit.Biopharm Drug Dispos. 1989 Mar-Apr;10(2):225-8. doi: 10.1002/bdd.2510100211. Biopharm Drug Dispos. 1989. PMID: 2706321
-
Pharmacokinetics of benzydamine after intravenous, oral, and topical doses to human subjects.Biopharm Drug Dispos. 1991 Oct;12(7):481-92. doi: 10.1002/bdd.2510120702. Biopharm Drug Dispos. 1991. PMID: 1932611 Clinical Trial.
-
Benzydamine: a critical review of clinical data.Int J Tissue React. 1985;7(3):229-35. Int J Tissue React. 1985. PMID: 3899972 Review.
-
Review of pharmacological data on benzydamine.Int J Tissue React. 1985;7(3):205-13. Int J Tissue React. 1985. PMID: 3899969 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials